ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

52 hedge funds and large institutions have $3.26M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
52
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$87.2K
2
+$51.5K
3
+$11K
4
Morgan Stanley
Morgan Stanley
New York
+$10.9K
5
BWP
Balboa Wealth Partners
Arizona
+$10.3K

Top Sellers

1
-$566K
2
-$43.3K
3
-$37K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$19.2K
5
CWA
CM Wealth Advisors
Ohio
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$11.9K
27
$11.1K
28
$11K
29
$10.4K
30
$10.1K
31
$8.17K
32
$7.33K
33
$7.09K
34
$6.92K
35
$6.46K
36
$6.07K
37
$4.05K
38
$3.95K
39
$3.46K
40
$2.2K
41
$2.07K
42
$1.73K
43
$1.26K
44
$500
45
$152
46
$104
47
$104
48
$25
49
$17
50
$13
1
2
3